Market Place
Sourcing Support
Merck, Bayer`s trial win for heart failure rival really boost Novartis` Entresto
20 Nov 2019 //
FIERCE PHARMA
Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF
18 Nov 2019 //
PR NEWSWIRE
Merck, Bayer`s trial win for heart failure rival really boost Novartis` Entresto
20 Oct 2019 //
FIERCE PHARMA
Merck, Bayer`s trial win for heart failure rival really boost Novartis` Entresto
20 Oct 2019 //
FIERCE PHARMA
Blow for Entresto in latest heart failure trial
29 Jul 2019 //
PMLIVE
IDT Biologika opens vaccine manufacturing facility in Germany
29 Jul 2019 //
FIERCE PHARMA
Zolgensma launch `on track and fully in line` with expectation, says CEO
19 Jul 2019 //
FIERCE PHARMA
Valsartan products not currently recalled - Updated November 27, 2018
28 Nov 2018 //
FDA
Pfizer`s Ibrance joins February`s TV ad-spending leaders
23 Mar 2018 //
FIERCE PHARMA
Renewed interest in ‘understudied’ co-crystals as better meds, say scientist
12 Mar 2018 //
IN PHARMATECHNOLOGIST
Big day looming, Novartis’ new CEO Vas Narasimhan readies his jump
24 Jan 2018 //
ENDPTS
Alcon`s return to growth gives Novartis `options`, says CEO
19 Jul 2017 //
PMLIVE
Cosentyx sales double, aiding Novartis Q2 earnings beat
18 Jul 2017 //
FIERCE PHARMA
Heart failure market to surpass $16 billion by 2026 as Novartis’ drug Entresto
03 Jul 2017 //
GLOBALDATA
New drugs can`t keep Novartis sales on the up
26 Apr 2017 //
PMLIVE
Novartis first-quarter profit slips as spending on Alcon, Entresto weighs
24 Apr 2017 //
REUTERS
Serelaxin`s demise ups the stakes on Novartis` latest Entresto-boosting moves
27 Mar 2017 //
FIERCE PHARMA
Amgen`s PCSK9 outcry, AZ`s SGLT2 death cuts, Xarelto`s aspirin beat
21 Mar 2017 //
FIERCE PHARMA
Novartis heart-failure med Entresto cuts A1c, insulin starts in diabetics
18 Mar 2017 //
FIERCE PHARMA
Ironwood`s colonic delivery platform a `pipeline within a pipeline
10 Mar 2017 //
FIERCE BIOTECH
Novartis sees weak Q4 and year, and expects a 2017 repeat
26 Jan 2017 //
FIERCE BIOTECH
Novartis Pulls Out of Controversial Entresto Contest
19 Dec 2016 //
MEDPAGE TODAY
Under drug-cost attack, Big Pharma CEOs raise the value-based pricing flag
07 Nov 2016 //
FIERCE PHARMA
Novartis Slows Gleevec Bleeding to Manage Q3 Beats amid Alcon`s Downward Spiral
26 Oct 2016 //
FIERCE PHARMA
Merck`s Diabetes Blockbuster Januvia Boards Pay-For-Performance Train with Aetna
13 Oct 2016 //
FIERCE PHARMA
Novartis intensifies Entresto push with new analysis
19 Sep 2016 //
REUTERS
How can Novartis sell more docs on Entresto? ESC experts have some ideas
31 Aug 2016 //
FIERCE PHARMA
Another big insurer will pay for key drugs based on patient outcomes
27 Jun 2016 //
STAT
Timely use of Novartis` Entresto could prevent or postpone over 28,000 US deaths
22 Jun 2016 //
PR NEWSWIRE
Why new data may reverse the slow start of Novartis` new heart med
17 Jun 2016 //
BIOPHARMA DIVE
Novartis willing to sell Roche stake without demanding premium - CEO
26 May 2016 //
REUTERS
Novartis launches new Entresto trials in bid to boost sales
20 May 2016 //
REUTERS
Novartis pharma head leaves as drug maker splits operations
18 May 2016 //
STAT
Cigna inks results-based deals on pricey Amgen, Sanofi PCSK9 meds
12 May 2016 //
FIERCE PHARMA
NICE backs restricted use of heart drug Entresto
28 Apr 2016 //
PHARMA TIMES
Novartis could refuel M&A machine with $14 billion Roche stake sale
26 Apr 2016 //
REUTERS
Novartis CEO: The racehorse drug launch is over in the U.S.
25 Apr 2016 //
FIERCE PHARMA MARKETING
New heart drugs struggle to win sales as doctors hold back
20 Apr 2016 //
REUTERS
Novartis takes Entresto case to U.S. cardiologist meeting
05 Apr 2016 //
REUTERS
ACC latest: Lilly, Merck, Pfizer, Novartis and more unveil key data
04 Apr 2016 //
FIERCE PHARMA
Analyst slashes Entresto sales forecast in half as skeptical heart docs hobble
23 Mar 2016 //
FIERCE PHARMA MARKETING
Novartis CEO sees pay drop to $11.9M on Alcon, emerging markets shortfalls
22 Mar 2016 //
FIERCE PHARMA
NICE confirms support for Novartis` heart drug Entresto
21 Mar 2016 //
PHARMATIMES
Former FDA Official Calls For Tougher Restrictions On Obesity Drug Contrave
08 Mar 2016 //
FORBES
Novartis sets heart-drug price with two insurers based on health outcome
10 Feb 2016 //
REUTERS
Three Drugs Could Catapult Three Big Pharma Revenues This Year
08 Feb 2016 //
BIOSPACE
Doctors pounce on `alarmist,` `horrifying` Novartis heart-failure ad
08 Feb 2016 //
FIERCE PHARMA
Novartis retrains Entresto reps, plans field force expansion
28 Jan 2016 //
FIERCE PHARMA MARKETING
US insurers dragging feet on covering new drugs, Novartis says
28 Jan 2016 //
REUTERS
Novartis divvies up troubled Alcon; rejigs R&D and manufacturing to save $1B
27 Jan 2016 //
FIERCE PHARMA
Novartis` Entresto launched in UK
21 Jan 2016 //
PM LIVE
No quick fix seen for Novartis`s troubled Alcon unit
11 Jan 2016 //
REUTERS
Promise Of High Prices Now Driving Biopharma R&D Investments
05 Jan 2016 //
FORBES
The biggest winners--and losers--in the 2015 race for new drug approvals
04 Jan 2016 //
FIERCE BIOTECH
Think different? Pharma turns to tech partnerships for beyond-the-pill moves
24 Dec 2015 //
FIERCE PHARMA
Novartis sees different drug pricing models: CEO in NZZ am Sonntag
22 Dec 2015 //
REUTERS
NICE nod for Novartis` revolutionary heart drug Entresto
14 Dec 2015 //
PHARMATIMES
UK cost agency endorses Novartis heart drug for some patients
11 Dec 2015 //
REUTERS
UK patients get early access to AZ`s lung cancer drug Tagrisso
09 Dec 2015 //
PM LIVE
Researcher Find Additional Benefit of Novartis AG`s Heart Failure Drug Entresto
03 Dec 2015 //
BIOSPACE
